156-57-0 | Sigma-Aldrich

Barbital solution (B8632)

70 eV Electron Ionization Mass Spectrum Abundance 41 83 98 141 156 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 11000 12000 13000 Hewlett-Packard 5890

BSK-H Medium Complete (B8291)

H.G., T.Dodd and C. Larson. (1982). Antigenic Variation of Borrelia Hermsii. J. Exp. Medicine 156:1297-1311. 3. Barbour, A. G., et al (1983). Isolation of Cultivable Spirochete from Ixodes ricinus

Data Sheet: Isopak™ Biochromatography Columns

94441322 1520 500–1000 76–152 57454WE 630x500x450 x 94631321 3119 50–500 16–156 57459WE 630x1000x500 x 94631322 3119 500–1000 156–312 57459WE 800x500x450 x 94801321 5027 50–500 25–251 57465WE 800x1000x500

MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors

103 23 56 31 10305 41 156 34 27 19 23 21 111 55 35 113 26 58 30 10428 40 159 33 std 7 26 19 23 24 122 53 39 104 23 54 31 17246

Product Information Sheet - S7276

clam Mya arenaria hemocytes following in vitro exposure to heavy metals. Toxicology, 142(2), 145-156 (2000). 13. Guadagnolo, C. M., et al., Chronic effects of silver exposure on ion levels, survival

Data Sheet - H2915

0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼57 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 156–212 nmole/min/mg (see Figure 2) Precautions and Disclaimer This

M Air T Sampling Head - A sampling system especially designed for barrier environments

30.12.70.00 Fax (01) 30.12.71.80 GERMANY Tel. (06196) 494-0 Fax (06196) 43901 HUNGARY Tel. 1-205 9784 Fax 1-205 9792 INDIA Tel. (91) 80-839 46 57 Fax (91) 80-839 63 45 ITALY Vimodrone (Milano): Tel

Spare parts for Mobius® FlexReady Solution with Smart Flexware® Assemblies For Chromatography and TFF

Transmitter AA SECTION A-A 156 154 20 Applicable for200MOD0 20 Applicable for200MOD1or 200MOD01 21 Applicable for200NOD4 154 156 20 20 21

Biological Evaluation of the MILLIPLEX®MAP Mouse High Sensitivity T Cell Panel

Cells 6.7 0 8.2 109 0.94 156 33 491 8.6 (+) PMA 24.2 0 10.4 134 1.35 216 110 803 12.2 (+) PHA 7.2 0 13.3 99 7.02 154 27 463 8.9 (+) Con A 8.9 0

hKv4.3/hKChIP1-CHO K1 Recombinant Cell Line

0 2 4 6 8 10 12 14 0 5 10 15 20 25 N um be r o f C el ls N um be r o f C el ls Kv4.3

hKv2.1/hKv9.2-CHO K1 Recombinant Cell Line

Passage 14715930 156 29 0 20 40 60 80 100 M e a n C u rr e n t A m p li tu d e >

User Guide

H C YT B -1 06 0- 2 (4 8- pl ex D et ec tio n M ix ) w it h L- S A PE -1 1 A va ila bl e

User Guide-HCYTB60K

H C YT B -1 06 0- 2 (4 8- pl ex D et ec tio n M ix ) w it h L- S A PE -1 1 A va ila bl e

H C YT B -1 06 0- 2 (4 8- pl ex D et ec tio n M ix ) w it h L- S A PE -1 1 A va ila bl e

Protocol- HTH17MAG-14K, HT17MG-14K-PX2, HT17MAG14PMX25BK

Standard 5 6.2 16 2,500 313 1,250 1,875 Standard 4 1.6 4 625 78 313 469 Standard 3 0.4 1 156 20 78 117 Standard 2 0.09 0.2 39 5 20 29

Protocol- HTH17SF-14K|HT17SF-14K-PX25

1,250 5,000 Standard 5 6.2 16 2,500 313 1,250 Standard 4 1.6 4 625 78 313 Standard 3 0.4 1 156 20 78 Standard 2 0.09 0.2 39 5 20

Protocol- HMYOMAG-56K

Standard 1 0.6 2 2 5 Standard 2 2.3 6 10 20 Standard 3 9.4 23 39 78 Standard 4 37.5 94 156 313 Standard 5 150 375 625 1,250

Protocol- PRCYTA-40K|PRCYTA-40K-PX38|PRCYTA-40K-BK38|PRCYTA-40K-PX48|PRCYTA-40K-BK48

T A -8 0 4 0 -1 (3 1 -p le x S ta n d a rd M ix ) P R C Y T A -8 0 4 0 -2 (4 8 -p le x S ta n d a rd M ix )

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

3 2071 3 215 2 207 3 257 3 483 5 IPI00399007 Hypothetical protein DKFZp 250 4 269 3 274 5 347 4 156 4 102 3 253 4 352 7 IPI00784998 Hypothetical protein DKFZp 139 3 141

Protocol: Human Th17 Magnetic Bead Panel

Standard 5 6.2 16 2,500 313 1,250 1,875 Standard 4 1.6 4 625 78 313 469 Standard 3 0.4 1 156 20 78 117 Standard 2 0.09 0.2 39 5 20 29

Raw Materials for Biopharmaceutical Manufacturing

Hydrochloride 156-57-0 100 gm, 1 kg Dextran Sulfate Sodium Salt RES2029D-A7 Dextran Sulfate Sodium Salt 9011-18-1 10 gm, 100 gm, 1 kg Ferric Ammonium Citrate RES20400-A7 Ferric Ammonium Citrate 1185-57-5 1

Protocol- CCYTOMAG-90K|CCYTMG-90K-PX13|CCYTMAG90KPX13BK

29 IL-6 35 IL-6 35 IL-7 36 IL-7 36 IL-8 48 IL-8 48 IL-15 54 IL-15 54 IP-10 57 IP-10 57 KC-like 61 KC-like 61 IL-10

MultiScreen Solubility Filter Plate: Determination of aqueous compound solubility using a 96-well filter plate.

50 50 12.5 12.5 3.13 3.13 0 0 500 500 200 200 50 50 12.5 12.5 3.13 3.13 0 0 500 500 200 200 50 50 12.5 12.5 3.13 3.13 0 0 500 500 200 200 50

Protocol- HTMP2MAG-54K

TIMP-3 (pg/mL) TIMP-4 (pg/mL) 1 20 49 98 10 2 78 195 391 39 3 313 781 1,563 156 4 1,250 3,125 6,250 625

Protocol- RADPCMAG-82K

Adiponectin (pg/mL) Standard 1 0.7 9.8 12 15 122 Standard 2 2.9 39 49 59 488 Standard 3 12 156 195 234 1,953 Standard 4 47 625 781 938 7,813

Protocol- RADPKMAG-80K

Insulin (pg/mL) Standard 1 0.7 9.8 12 15 24 Standard 2 2.9 39 49 59 98 Standard 3 12 156 195 234 391 Standard 4 47 625 781 938 1,563

Protocol: Rat Adipocyte Magnetic Bead Panel

Adiponectin (pg/mL) Standard 1 0.7 9.8 12 15 122 Standard 2 2.9 39 49 59 488 Standard 3 12 156 195 234 1,953 Standard 4 47 625 781 938 7,813

Protocol- HTMP2MAG-54K

TIMP-3 (pg/mL) TIMP-4 (pg/mL) 1 20 49 98 10 2 78 195 391 39 3 313 781 1,563 156 4 1,250 3,125 6,250 625

Product Information Sheet-xtg360-ro

eukaryotic cells. Cat. No. 08 724 105 001 0.4 ml Cat. No. 08 724 121 001 1.0 ml Cat. No. 08 724 156 001 5 x 1.0 ml Store the reagent at −15 to −25°C.

BRAND Katalog EN

Description Grip width mm Holding distance mm Cat. No. 360° swivelling 0 - 57 115 5770 57 90° rigid 0 - 57 115 5778 57 Jaw c lamp wi th in tegra l